| β受体阻断药用药趋势分析 |
| 投稿时间：2005-05-12 点此下载全文 |
| 引用本文：匡玉霞.β受体阻断药用药趋势分析[J].药学实践杂志,2005,(5):282~284 |
| 摘要点击次数: 861 |
| 全文下载次数: 920 |
|
|
| 中文摘要:目的 了解β受体阻断药应用状况及变化趋势,为临床合理用药提供科学依据.方法 对武汉亚洲心脏病医院2003-2004年应用β受体阻断药的数据资料进行统计分析.结果 β受体阻断药的用药金额和用药频度逐年增加.结论 我院β受体阻断药用药合理,第二代β受体阻断药美托洛尔、阿替洛尔仍占主导地位. |
| 中文关键词:β受体阻断剂 DDD 用药频度 |
| |
| Analysis on usage of β-receptor blocking drugs |
|
|
| Abstract:Objective To investigate the status and tendency of β-receptor antagonists usage, and offer scientific basis for reasonable usage of the drugs in clinic treatment. Methods The data of β-receptor antagonists usage in Wuhan Asia Heart Hospital during 2003 to 2004 were collected and analyzed. Results The expense and frequency of β-receptor antagonists usage increase year by year. Conclusion The usage of p-receptor antagonists is reasonable in our hospital. The second generation of β-receptor antagonists, such as metoprolol and atenolol, are dominant in clinic use. |
| keywords:β-receptor antagonists DDD usage frequency of drugs |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
|
|
|
